Tim Noakes has been Medical Propellants Business Expert at Mexichem over the last 20+ years and has developed unique access to and insight into pressurized metered dose inhaler manufacturing around the world. He gives OINDPnews.com his perspective on how the industry has been evolving, especially in the developing world. Read Part 1 Q: What trends are you … [Read more...] about A Q&A with Tim Noakes of MexiChem, Part 2
Features
A Q&A with Tim Noakes of MexiChem, Part 1
As Medical Propellants Business Expert at Mexichem over the last 20+ years, Tim Noakes has developed unique access to and insight into pressurized metered dose inhaler manufacturing around the world. He gives OINDPnews.com his perspective on how the industry has been evolving, especially in the developing world. Q:What has been the most significant change in MDI … [Read more...] about A Q&A with Tim Noakes of MexiChem, Part 1
From inhalable vaccines to inhalable caffeine (updated March 7, 2012)
Update 3/7/2012: The FDA issues a warning letter on inhalable caffeine. Update 2/19/2012: The FDA says it will review the safety and legality of AeroShot inhaled caffeine. In 2008, Harvard professor David Edwards gave a talk to the AAPS Inhalation and Nasal Technology Focus Group (INTFG) titled "Inhaled Drugs and Vaccines for Infectious Diseases in Low-Income … [Read more...] about From inhalable vaccines to inhalable caffeine (updated March 7, 2012)
Aerosol School offers comprehensive introduction to inhaled and nasal drugs
In early April, up to 20 scientists, technicians, and students from around the world will gather in a laboratory at the Firestone Institute for Respiratory Health in Hamilton, Ontario, Canada for an intensive course known as "Aerosol School." Over a three-day period, the 20 participants from industry and academia will learn the basics of aerosol medicine formulation, … [Read more...] about Aerosol School offers comprehensive introduction to inhaled and nasal drugs
DDL 22 — Day 3
DDL 22 finished up on Friday, December 9 with a series of talks related to physical and physicochemical properties of inhaled drugs, including several presentations by graduate students. Despite the fact that many delegates had taken shelter from the previous evening's tropical storm-force winds in Edinburgh in nearby pubs, a reasonable number of them appeared in the … [Read more...] about DDL 22 — Day 3
DDL 22 — Day 2
Day 2 of DDL 22 started off with a focus on delivery devices, beginning with a talk by Professor Myrna Dolovich of McMaster University on selecting the correct device for patients and ending with a panel discussion between four "champions": Stephen Stein of 3M championing MDIs, David Harris of Team Consulting championing DPIs, Philippe Rogueda of Monash University … [Read more...] about DDL 22 — Day 2
DDL 22 — Day 1
Nearly 500 people attended the first day of the 2011 Drug Delivery to the Lungs meeting (DDL 22) at the Edinburgh International Conference Centre. Approximately 50 of the DDL 22 attendees were also registered for the ISAM workshop on lung imaging standardization which took place in the morning prior to the opening of the main conference. The meeting opened with an … [Read more...] about DDL 22 — Day 1
Moving toward a greener inhaler
The approximately 800 million inhalers sold annually worldwide generate approximately 10,000 tons of waste, estimates Graham Purkins of Novartis, a member of the the Device Working Group of IPAC-RS. In response to growing concern from consumers, clinicians, and manufacturers, the working group has undertaken a project to begin a conversation among inhaler designers … [Read more...] about Moving toward a greener inhaler
The USP Aerosols–Inhalation and Nasal Drug Products Workshop
The upcoming Aerosols–Inhalation and Nasal Drug Products Workshop sponsored by the United States Pharmacopoeia’s General Chapters-Dosage Forms Expert Committee will take place at USP headquarters in Rockville, MD on December 12 and 13, and the organizers are expecting that up to 75 OINDP specialists from industry, academia, and regulatory agencies will … [Read more...] about The USP Aerosols–Inhalation and Nasal Drug Products Workshop
DDL 22 provides scientific and networking opportunities for OINDP specialists
The 2011 Drug Delivery to the Lungs (DDL) Conference, which takes place December 7-9 in Edinburgh, UK, will highlight a particularly strong field of scientific presentations from both established industry experts and up-and-coming young researchers, according to DDL committee member and Treasurer, Mark Hammond. In addition, Hammond says, this year’s conference will … [Read more...] about DDL 22 provides scientific and networking opportunities for OINDP specialists